3-hydroxyflavone has been researched along with Liver Dysfunction in 6 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 2 (33.33) | 18.2507 |
2000's | 1 (16.67) | 29.6817 |
2010's | 1 (16.67) | 24.3611 |
2020's | 2 (33.33) | 2.80 |
Authors | Studies |
---|---|
Ding, P; Ji, G; Wang, J; Wang, Y; Wu, T; Xiang, H | 1 |
Bi, Y; Chen, J; Fu, J; Liu, B; Wang, X; Xia, T; Zhu, R | 1 |
Chen, J; Chen, Y; Chi, X; Guo, D; Jiang, Y; Jiang, Z; Lin, J; Lv, L; Pi, H; Qin, W; Yang, H | 1 |
Küpeli, E; Orhan, DD; Yesilada, E | 1 |
Bioque, G; Closa, D; Gelpí, E; Hotter, G; León, OS; Rósello-Catafau, J; Torres, M | 1 |
Cao, J; Chen, T; Jiang, J; Koda, A; Saiki, I; Wu, F; Xu, Q | 1 |
2 review(s) available for 3-hydroxyflavone and Liver Dysfunction
Article | Year |
---|---|
Recent update on application of dihydromyricetin in metabolic related diseases.
Topics: AMP-Activated Protein Kinases; Anti-Inflammatory Agents; Antioxidants; Cell Death; Flavonols; Glucose; Humans; Lipid Metabolism; Liver Diseases; Metabolic Diseases; MicroRNAs; Neoplasms; Oxidative Stress; Peroxisome Proliferator-Activated Receptors; Phosphatidylinositol 3-Kinases; Proto-Oncogene Proteins c-akt; Signal Transduction | 2022 |
Molecular mechanisms and therapeutic implications of dihydromyricetin in liver disease.
Topics: Carcinoma, Hepatocellular; Flavonols; Humans; Liver Diseases; Liver Diseases, Alcoholic; Liver Failure, Acute; Liver Neoplasms; Liver Regeneration; Non-alcoholic Fatty Liver Disease; Protective Agents | 2021 |
4 other study(ies) available for 3-hydroxyflavone and Liver Dysfunction
Article | Year |
---|---|
Dihydromyricetin protects against liver ischemia/reperfusion induced apoptosis via activation of FOXO3a-mediated autophagy.
Topics: Animals; Apoptosis; Autophagy; Caspase 3; Disease Models, Animal; Flavonols; Forkhead Box Protein O3; Liver Diseases; Mice; Mice, Inbred C57BL; Phosphorylation; Protective Agents; Reperfusion Injury | 2016 |
Effect of Cistus laurifolius L. leaf extracts and flavonoids on acetaminophen-induced hepatotoxicity in mice.
Topics: Acetaminophen; Alanine Transaminase; Animals; Antioxidants; Aspartate Aminotransferases; Chemical and Drug Induced Liver Injury; Cistus; Flavonoids; Flavonols; Glutathione; Kaempferols; Lipid Peroxidation; Liver; Liver Diseases; Male; Malondialdehyde; Mice; Plant Extracts; Plant Leaves; Quercetin; Turkey | 2006 |
Prostanoids and free radicals in Cl4C-induced hepatotoxicity in rats: effect of astilbin.
Topics: 6-Ketoprostaglandin F1 alpha; Animals; Antioxidants; Carbon Tetrachloride; Chemical and Drug Induced Liver Injury; Dinoprostone; Female; Flavonoids; Flavonols; Free Radicals; Lipid Peroxidation; Liver; Liver Diseases; Malondialdehyde; Molecular Structure; Phospholipases A; Prostaglandins; Rats; Rats, Sprague-Dawley; Superoxide Dismutase; Thromboxane B2; Vitamin E | 1997 |
Astilbin selectively induces dysfunction of liver-infiltrating cells--novel protection from liver damage.
Topics: Animals; Antioxidants; Apoptosis; Carbon Tetrachloride; Chemical and Drug Induced Liver Injury; DNA Fragmentation; Drugs, Chinese Herbal; Flavonoids; Flavonols; Hypersensitivity, Delayed; Liver; Liver Diseases; Male; Mice; Mice, Inbred BALB C; Mice, Inbred ICR; Picryl Chloride; Spleen; Transaminases | 1999 |